Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  25,091 results for ""Verteporfin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Verteporfin combined with ROCK inhibitor promotes the restoration of corneal endothelial cell dysfunction in rats.

  • Authors : Zhang X; Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, PR China; Key Lab of Visual Damage and Regeneration, Chongqing, 401329, PR China.

Subjects: Verteporfin*/Verteporfin*/Verteporfin*/pharmacology ; Verteporfin*/Verteporfin*/Verteporfin*/therapeutic use ; rho-Associated Kinases*/rho-Associated Kinases*/rho-Associated Kinases*/antagonists & inhibitors

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2025 Jan; Vol. 231, pp. 116641. Date of Electronic Publication: 2024 Nov 19.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Verteporfin is an effective inhibitor of HCMV replication.

  • Authors : Lim WY; Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, South Korea.; Lee JH

Subjects: Virus Replication*/Virus Replication*/Virus Replication*/drug effects ; Cytomegalovirus*/Cytomegalovirus*/Cytomegalovirus*/drug effects ; Cytomegalovirus*/Cytomegalovirus*/Cytomegalovirus*/physiology

  • Source: Virus research [Virus Res] 2024 Dec; Vol. 350, pp. 199475. Date of Electronic Publication: 2024 Oct 08.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8410979 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Circ_0002722-induced regulation of YAP promotes platinum resistance in oral squamous cell carcinoma: Implications for verteporfin therapy.

  • Authors : Tsai HC; Department of Medicine Research, China Medical University Beigang Hospital, Yunlin, Taiwan.; Tsai MH

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/drug therapy

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2024 Nov; Vol. 229, pp. 116460. Date of Electronic Publication: 2024 Aug 02.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells.

  • Authors : Wang XW; Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, 030001, China.; Yang ZY

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects

  • Source: Molecular biotechnology [Mol Biotechnol] 2024 Sep; Vol. 66 (9), pp. 2558-2568. Date of Electronic Publication: 2023 Sep 26.Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Verteporfin-Loaded Bioadhesive Nanoparticles for the Prevention of Hypertrophic Scar.

  • Authors : Wang P; Department of Burn and Wound Repair Surgery, The First Affiliated Hospital of Sun Yat-senUniversity, No.58, Zhongshan 2nd Road, Guangzhou, 510080, China.; Peng Z

Subjects: Cicatrix, Hypertrophic*/Cicatrix, Hypertrophic*/Cicatrix, Hypertrophic*/drug therapy ; Cicatrix, Hypertrophic*/Cicatrix, Hypertrophic*/Cicatrix, Hypertrophic*/prevention & control ; Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry

  • Source: Small methods [Small Methods] 2024 Aug; Vol. 8 (8), pp. e2301295. Date of Electronic Publication: 2023 Dec 12.Publisher: WILEY-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 101724536 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Functional and anatomical results of subthreshold micropulse laser as rescue treatment for central serous chorioretinopathy after verteporfin shortage.

  • Authors : Oribio-Quinto C; Department of Ophthalmology, Fundación para la investigación biomédica Hospital Clínico San Carlos (IdISCC), Madrid, Spain. Electronic address: .; Alarcón-Garcia AD

Subjects: Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/surgery ; Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/Central Serous Chorioretinopathy*/drug therapy ; Verteporfin*/Verteporfin*/Verteporfin*/therapeutic use

  • Source: Photodiagnosis and photodynamic therapy [Photodiagnosis Photodyn Ther] 2024 Oct; Vol. 49, pp. 104295. Date of Electronic Publication: 2024 Jul 25.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101226123 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy.

  • Authors : Qi J; Institute of Nervous System Diseases, Xuzhou Medical University, 84 West Huaihai Road, Xuzhou, 221002, Jiangsu, China.; The Graduate School, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Aug 20; Vol. 22 (1), pp. 495. Date of Electronic Publication: 2024 Aug 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

Read More Add to Saved list
×
Academic Journal

Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study.

  • Authors : Yusuf IH; Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, Oxford University, West Wing, John Radcliffe Hospital, Oxford, OX3 9DU, UK. .; Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Headley Way, Oxford, OX3 9DU, UK. .

Subjects: Ranibizumab*/Ranibizumab*/Ranibizumab*/therapeutic use ; Ranibizumab*/Ranibizumab*/Ranibizumab*/administration & dosage ; Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods

  • Source: Eye (London, England) [Eye (Lond)] 2024 Aug; Vol. 38 (Suppl 2), pp. 39-40. Date of Electronic Publication: 2023 Apr 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Photodynamic therapy with verteporfin accelerates apoptotic bleb formation in human ameloblastoma.

  • Authors : Yamashita J; Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.; Kimoto A

Subjects: Verteporfin*/Verteporfin*/Verteporfin*/therapeutic use ; Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods ; Photosensitizing Agents*/Photosensitizing Agents*/Photosensitizing Agents*/therapeutic use

  • Source: Oral diseases [Oral Dis] 2024 Jul; Vol. 30 (5), pp. 3261-3271. Date of Electronic Publication: 2023 Oct 27.Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9508565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1601-0825

Record details

Read More Add to Saved list
×
Academic Journal

A Physiochemical, In Vitro, and In Vivo Comparative Analysis of Verteporfin-Lipid Conjugate Formulations: Solid Lipid Nanoparticles and Liposomes.

  • Authors : Shah N; Department of Bioengineering, University of Texas at Dallas, Richardson, Texas 75080, United States.; Soma SR

Subjects: Liposomes*/Liposomes*/Liposomes*/chemistry ; Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry ; Verteporfin*/Verteporfin*/Verteporfin*/chemistry

  • Source: ACS applied bio materials [ACS Appl Bio Mater] 2024 Jul 15; Vol. 7 (7), pp. 4427-4441. Date of Electronic Publication: 2024 Jun 27.Publisher: ACS Publications Country of Publication: United States NLM ID: 101729147 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  25,091 results for ""Verteporfin""